
The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using CSB-PA017010(CLPTM1L Antibody) at dilution 1/60, on the right is treated with synthetic peptide. (Original magnification: x200)
CLPTM1L Antibody
CSB-PA017010
ApplicationsELISA, ImmunoHistoChemistry
Product group Antibodies
TargetCLPTM1L
Overview
- SupplierCusabio
- Product NameCLPTM1L Antibody
- Delivery Days Customer20
- ApplicationsELISA, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID81037
- Target nameCLPTM1L
- Target descriptionCLPTM1 like
- Target synonymscisplatin resistance related protein CRR9p; cisplatin resistance-related protein 9; cleft lip and palate transmembrane protein 1-like protein; CLPTM1-like protein; CRR9
- HostRabbit
- IsotypeIgG
- Protein IDQ96KA5
- Protein NameCleft lip and palate transmembrane protein 1-like protein
- Scientific DescriptionCleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein), also known as cisplatin resistance-related protein 9 (CRR9p), is a protein that in humans is encoded by the CLPTM1L gene. CRR9p is associated with cisplatin-induced apoptosis. CLPTM1L, which lies within a cancer susceptibility locus on chromosome 5 (5p15.33), has been found to be commonly over-expressed in lung tumors and to confer resistance to apoptosis caused by genotoxic agents in association with up-regulation of the anti-apoptotic protein, Bcl-xL.
- Storage Instruction-20°C or -80°C
- UNSPSC12352203